Leptin, insulin and thyroid hormones in a cohort of Egyptian obese Down syndrome children: A comparative study

BMC Endocrine Disorders

Volumn 12, Issue , 2012, Pages

  Yahia, Sohier ^a   EL farahaty, Reham M ^a   El Hawary, Amany K ^a   El hussiny, Mona A ^a   Abdel maseih, Hanaa ^a   El Dahtory, Faeza ^a   El Gilany, Abdel Hady ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Down syndrome; Insulin resistance; Leptin; Leptin resistance; Obesity

Indexed keywords

CREATINE KINASE; GLUCOSE; INSULIN; LEPTIN; THYROID HORMONE; THYROTROPIN;

ARTICLE; BLOOD SAMPLING; BODY MASS; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; DOWN SYNDROME; EGYPT; FEMALE; FREE THYROXINE INDEX; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; INSULIN RESISTANCE; MALE; OBESITY; PREPUBERTY; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 84867365426     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-12-22     Document Type: Article

References (41)

1. Grammatikopoulou MG, Manai A, Tsigga M, Tsiligiroglou-Fachantidou A, Galli-Tsinopoulou A, Zakas A. Nutrient intake and anthropometry in children and adolescents with Down syndrome - a preliminary study. Dev Neurorehabil 2008, 11(4):260-7. 10.1080/17518420802525526, 19031198.
2. Murray J, Ryan-Krause P. Obesity in children with Down syndrome: background and recommendations for management. Pediatr Nurs 2010, 36(6):314-9.
3. Whitt-Glover MC, O'Neill KL, Stettler N. Physical activity patterns in children with and without Down syndrome. Pediatr Rehabil 2006, 9(2):158-64.
4. Konings CH, Van Trotsenburg AS, Ris-Stalpers C, Vulsma T, Wiedijk BM, De Vijider JJ. Plasma thyrotropin bioactivity in Down syndrome children with subclinical hypothyroidism. Euro J Endocrinol 2001, 144:1-4.
5. Luke A, Sutton M, Schoeller DA, Roizen NJ. Nutrient intake and obesity in prepubescent children with Down syndrome. J Am Diet Assoc 1996, 96:1262-7. 10.1016/S0002-8223(96)00330-6, 8948387.
6. Reinehr T, Dobe M, Winkel K, Schaefer A, Hoffmann D. Obesity in Disabled Children and Adolescents An Overlooked Group of Patients. Dtsch Arztebl Int 2010, 107(15):268-75. 2864441, 20458368.
7. Bricout VA. Endocrine and autonomic nervous adaptations during physical exercise in Down syndrome. Genetics and etiology of Down syndrome 2011, 236. Tech publisher, Dey S, Available from: http://www.intechopen.com/books/genetics-and-etiology-of-down syndrome/endocrine-and-autonomic-nervous-adaptations-during-physical-exercise-in-down-syndrome, 2011.
8. Melville CA, Cooper SA, McGrother CW, Thorp CF, Collacott R. Obesity in adults with Down syndrome: a case-control study. Intellectual Disability Res J 2005, 49(2):125-33.
9. Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JP. Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 2008, 149(4):1581-90. 10.1210/en.2007-1148, 2276706, 18096662.
10. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive leptin .concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-5. 10.1056/NEJM199602013340503, 8532024.
11. Lopaschuk GD, Ussher JR, Jaswal JS. Targeting intermediary metabolism in the hypothalamus as a mechanism to regulate appetite. Pharmacol Rev 2010, 62:237-264. 10.1124/pr.109.002428, 20392806.
12. Ten S, Maclaren N. Insulin Resistance Syndrome in children. J Clin Endocrinol Metab 2004, 89(6):2526-39. 10.1210/jc.2004-0276, 15181020.
13. Myrelid A, Gustafsson J, Ollars B, Annerén G. Growth charts for Down's syndrome from birth to 18 years of age. Arch Dis Child 2002, 87:97-103. 10.1136/adc.87.2.97, 1719180, 12138052.
14. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976, 51:170-9. 10.1136/adc.51.3.170, 1545912, 952550.
15. Tietz NW. Clinical guide to laboratory tests 1995, 268-73. Philadelphia: WB Saunders, 3.
16. Reeves WG. Insulin antibody determination: theoretical and practical considerations. Diabetologia 1983, 24:399-403.
17. Nicoloff JT, Spencer CA. The use and misuse of the sensitive thyrotropin assays. J Clin Endoc Metab 1990, 71:553-58.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment:insulin resistance and β-cell function from fasting blood glucose and insulin concentrations in man. Diabetologia 1985, 28:412-19. 10.1007/BF00280883, 3899825.
19. Lee JH, Reed DR, Price RA. Leptin resistance is associated with extreme obesity and aggregates in families. Int J Obes 2001, 25:1471-3.
20. Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eurpean Journal of Endocrinology 2008, 159:s67-s74.
21. American Diabetes Association Diagnosis and classification of Diabetes mellitus. Diabetes Care 2011, 34:s62-s69. 3006051, 21193628, American Diabetes Association.
22. Fonseca CT, Amaral DM, Ribeiro MG, Beserra IC, Guimaraes MM. Insulin resistance in adolescents with Down syndrome: a cross-sectional study. BMC Endocr Disord 2005, 5:1-6. 10.1186/1472-6823-5-1, 553971, 15737232.
23. Bare MT, Waldron J, Gumm H, Van Dyke DC, Chang H. Nutrition assessment of the child with Down syndrome. Clinical perspectives in the management of Down syndrome 1990, 107-25. USA: Springer-Verlag New York Inc, Van Dyke DC, Lang DJ, Heide F, Van Duyne S, Soucek MJ.
24. Magge SN, O'Neill KL, Shults J, Stallings VA, Stettler N. Leptin levels among prepubertal children with Down syndrome compared with their siblings. J Pediatr 2008, 152(3):321-6. 10.1016/j.jpeds.2007.08.008, 2267910, 18280834.
25. Steinbeck KS. Insulin resistance syndrome in children and adolescent: clinical meaning and indication for action. Int J Obesity 2004, 28:829-32.
26. Flore P, Bricout VA, Van Biesen D, Guinot M, Laporte F, Pépin JL, Eberhard Y, Favre-Juvin A, Wuyam B, van de Vliet P, Faure P. Oxidative stress and metabolism at rest and during exercise in persons with Down syndrome. Eur J Cardiovasc Prev Rehabil 2008, 15:35-42. 10.1097/HJR.0b013e3282f2bff3, 18277183.
27. Martin SS, Qasim A, Reilly MP. Leptin resistance. A possible interface of inflammation and metabolism in obesity-related cardiovascular disease. JACC 2008, 52:1201-10.
28. Shaw CK, Thapalial A, Nanda S, Shaw P. Thyroid dysfunction in Down syndrome. KUMJ 2006, 4(2):182-6.
29. Kapelari K, Kirchlechner C, Högler W, Schweitzer K, Virgolini I, Moncayo R. Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study. BMC Endocr Disord 2008, 8:15. 10.1186/1472-6823-8-15, 2645400, 19036169.
30. Kupke IR, Tritschler W, Kather B, Bablk W. Creatine kinase NAC activated reference values for children. Klin Padiator 1980, 192(4):348-50.
31. Clarkson PM, Hoffman EP, Zambraski E, Gordish-Dressman H, Kearns A, Hubal M, et al. ACTN3 and MLCK genotype associations with exertional muscle damage. J Appl Physiol 2005, 99:564-9. 10.1152/japplphysiol.00130.2005, 15817725.
32. Totsuka M, Nakaji S, Suzuki K, Sugawara K, Sato K. Break point of serum creatine kinase release after endurance exercise. J Appl Physiol 2002, 93:1280-6.
33. Ebbeling CB, Clarkson PM. Exercise-induced muscle damage and adaptation. Sports Med 1989, 7:207-34. 10.2165/00007256-198907040-00001, 2657962.
34. Gledhill RF, Van der merwe CA, Greyling TM, Van Niekerkt MM. Race-gender differences in serum creatine kinase activity: a study among South Africans. J of Neurology, Neurosurgery, and Psychiatry 1988, 51:301-304.
35. Pavlu J, Carey MP, Winer JB. Hypothyroidism and nemaline myopathy in an adult. J Neurol Neurosurg Psychiatry 2006, 77:708-9. 10.1136/jnnp.2005.079293, 2117463, 16614046.
36. Kumar K, Guirgis M, Zieroth S, Lo E, Menkis AH, Arora RC, Freed DH. Influenza myocarditis and myositis: case presentation and review of the literature. Can J Cardiol 2011, 27:514-22. 10.1016/j.cjca.2011.03.005, 21652168.
37. Al Husain M. Body mass index for Saudi children with Down's syndrome. Acta Paediatric 2003, 92:1482-5.
38. Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. Obes Rev 2004, 5:4-10. 10.1111/j.1467-789X.2004.00133.x, 15096099.
39. Freedman DS, Sherry B. The Validity of BMI as an indicator of body fatness and risk among children. Pediatrics 2009, 124(S 1):523-34.
40. González-Agüero A, Ara I, Moreno LA, Vicente-Rodríguez G, Casajús JA. Fat and lean masses in youths with Down syndrome: gender differences. Res Dev Disabil 2011, 32(5):1685-93. 10.1016/j.ridd.2011.02.023, 21435834.
41. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007, 120:s164-s92. 10.1542/peds.2007-2329C, 18055651.